Cardiovascular diseases in congenital prekallikrein deficiency: comparison with other chance-associated morbidities

&NA; To compare the prevalence of cardiovascular diseases with other chance-associated morbidities in patients with congenital prekallikrein deficiency. Patients with prekallikrein deficiency were gathered from two time unlimited PubMed searches and from personal files. Inclusion criteria were prekallikrein level less than 15% of normal; correction of aPTT on long incubation times; prolonged aPTT corrected by normal plasma or serum; normal prothrombin time and normal FXII and FXI. Acquired forms were excluded. Out of 106 patients, we have found that 45 patients had at least one chance-associated defect or morbidity at the time of the diagnosis of the clotting defect. Twenty-nine of these 45 patients had cardiovascular disorders. Other comorbidities were found in a much smaller proportion. Congenital prekallikrein deficiency is frequently associated with cardiovascular conditions, namely hypertension, coronary disease, ischemic stroke, venous thrombosis. The significance of these findings is critically discussed as association between two diseases does not necessarily indicate the existence of a causative relation between the two. However, the findings presented here clearly indicate the possibility that such a relation might indeed exist.

[1]  S. Just,et al.  Prekallikrein deficiency. , 2020, Pathology.

[2]  F. Declau,et al.  Prekallikrein deficiency in a 15-year-old boy with Ménière’s disease: a case report , 2017, Acta clinica Belgica.

[3]  T. Renné,et al.  A comparison of the effects of factor XII deficiency and prekallikrein deficiency on thrombus formation. , 2016, Thrombosis research.

[4]  A. Schmaier,et al.  The contact activation and kallikrein/kinin systems: pathophysiologic and physiologic activities , 2016, Journal of thrombosis and haemostasis : JTH.

[5]  A. Girolami,et al.  The Old and the New in Prekallikrein Deficiency: Historical Context and a Family from Argentina with PK Deficiency due to a New Mutation (Arg541Gln) in Exon 14 Associated with a Common Polymorphysm (Asn124Ser) in Exon 5 , 2014, Seminars in Thrombosis & Hemostasis.

[6]  R. A. Archer,et al.  Complete prekallikrein deficiency masquerading as a lupus anticoagulant. , 2014, Thrombosis research.

[7]  Thomas Quail,et al.  Prekallikrein Deficiency , 2013, Journal of pediatric oncology nursing : official journal of the Association of Pediatric Oncology Nurses.

[8]  A. Loaiza-Bonilla,et al.  Prekallikrein Deficiency Presenting as Recurrent Cerebrovascular Accident: Case Report and Review of the Literature , 2012, Case reports in hematology.

[9]  A. Lombardi,et al.  Congenital prekallikrein deficiency , 2010, Expert review of hematology.

[10]  A. Lombardi,et al.  A large family from Argentina with Prekallikrein deficiency due to a compound heterozygosis (T insertion in intron 7 and Asp558Glu in exon 15): Prekallikrein Cordoba , 2010, American journal of hematology.

[11]  S. Unal,et al.  A Challenging Diagnosis of Homozygous Prekallikrein Deficiency During the Preoperative Evaluation of an Infant With Intractable Seizures: A Literature Review of Surgical Management in This Disorder , 2010 .

[12]  C. Hermans,et al.  Management of prekallikrein deficiency during cardiac surgery , 2010, Thrombosis and Haemostasis.

[13]  D. Alexandrescu,et al.  A case of prekallikrein deficiency resulting in severe recurrent mucosal hemorrhage. , 2009, The American journal of the medical sciences.

[14]  F. España,et al.  Fletcher factor deficiency: report of a new family. , 2009, Scandinavian journal of haematology.

[15]  M. Makris,et al.  Contact factor deficiencies and cardiopulmonary bypass surgery: detection of the defect and monitoring of heparin , 2009, European journal of haematology.

[16]  D. McGiffin,et al.  Practical approach to anticoagulation for cardiopulmonary bypass in the patient with congenital prolonged activated partial thromboplastin time. , 2008, Blood Coagulation and Fibrinolysis.

[17]  D. Seiffert,et al.  A renaissance for the contact system in blood coagulation? , 2008, Thrombosis and Haemostasis.

[18]  A. Schmaier,et al.  The plasma kallikrein–kinin system: its evolution from contact activation , 2007, Journal of thrombosis and haemostasis : JTH.

[19]  T. Renné,et al.  Intrinsic Pathway of Coagulation and Arterial Thrombosis , 2007, Arteriosclerosis, thrombosis, and vascular biology.

[20]  A. Mumford,et al.  Management of anticoagulation for coronary artery bypass surgery in a patient with severe prekallikrein deficiency. , 2006, Journal of cardiothoracic and vascular anesthesia.

[21]  D. Bowden,et al.  Severe prekallikrein deficiency associated with homozygosity for an Arg94Stop nonsense mutation , 2004, British journal of haematology.

[22]  A. Lombardi,et al.  Severe prekallikrein (Fletcher factor) deficiency due to a compound heterozygosis (383Trp stop codon and Cys529Tyr) , 2003, Thrombosis and Haemostasis.

[23]  G. Lutze,et al.  Präkallikrein-(Fletcher-Faktor-)Defekt als Ursache einer präoperativen APTT-Verlängerung , 2003, Medizinische Klinik.

[24]  T. Shigekiyo,et al.  Prekallikrein (PK) Tokushima: PK deficiency caused by a Gly401→Glu mutation , 2003, Journal of thrombosis and haemostasis : JTH.

[25]  C. Kitchens.  The contact system. , 2002, Archives of pathology & laboratory medicine.

[26]  A. Jillella,et al.  Prolonged Partial Thromboplastin Time Without Bleeding History; Fletcher Factor Deficiency. , 2002, Turkish journal of haematology : official journal of Turkish Society of Haematology.

[27]  B. Lämmle,et al.  Prekallikrein deficiency: the characteristic normalization of the severely prolonged aPTT following increased preincubation time is due to autoactivation of factor XII. , 2002, Thrombosis research.

[28]  O. Wenker,et al.  Fletcher Factor Deficiency in Cardiac Anesthesia A Case Report , 1996 .

[29]  H. Weiss,et al.  Spinal anesthesia in a patient with prekallikrein deficiency. , 1996, Anesthesia and analgesia.

[30]  B. Lämmle,et al.  Functional Characterization of a Variant Prekallikrein (PK Zürich) , 1993, Thrombosis and Haemostasis.

[31]  G. Leone,et al.  Association of Graves' disease and prekallikrein congenital deficiency in a patient belonging to the first CRM+ prekallikrein-deficient Italian family. , 1990, Thrombosis research.

[32]  K. Rickard,et al.  Multiple cerebral thrombosis in fletcher factor (prekallikrein) deficiency: A case report , 1985, American journal of hematology.

[33]  L. Goodnough,et al.  Thrombosis or Myocardial Infarction in Congenital Clotting Factor Abnormalities and Chronic Thrombocytopenias: A Report of 21 Patients and a Review of 50 Previously Reported Cases , 1983, Medicine.

[34]  J. Soria,et al.  Heterogeneity of human prekallikrein deficiency (Fletcher trait): evidence that five of 18 cases are positive for cross-reacting material. , 1981, The New England journal of medicine.

[35]  F. Laduca,et al.  Fletcher factor deficiency, source of variations of the activated partial thromboplastin time test. , 1981, American journal of clinical pathology.

[36]  Brown Ja,et al.  Plasma prekallikrein (Fletcher factor) deficiency in a patient with chronic lymphocytic leukemia. , 1980 .

[37]  V. Vinciguerra,et al.  Fletcher factor deficiency and myocardial infarction. , 1976, American journal of clinical pathology.

[38]  W. Hathaway,et al.  Evidence for a new plasma thromboplastin factor. I. Case report, coagulation studies and physicochemical properties. , 1965, Blood.

[39]  L. Conti,et al.  Prolungamento del tempo di tromboplastina parziale attivata in una paziente asintomatica: La carenza di precallicreina , 2015 .

[40]  K. Acar,et al.  Isolated prolonged activated partial thromboplastin time in an asymptomatic patient: Fletcher factor deficiency. , 2006, Thrombosis research.

[41]  C. Raffoux,et al.  HLA typing in a new family with fletcher factor deficiency , 2004, Human Genetics.

[42]  D. Hess,et al.  Stroke in a young adult with Fletcher trait. , 1991, Southern medical journal (Birmingham, Ala. Print).

[43]  P. Kyrle,et al.  CRM+ severe Fletcher factor deficiency associated with Graves' disease. , 1984, Haemostasis.